Strategic Industry Ventures (SIV) is responsible for connecting MD Anderson Cancer Center to Industry with the goal of bringing new drugs, diagnostics, devices, imaging agents and information solutions to the market for the benefit of cancer patients.
This goal is met through two main functions:
SIV assists companies looking to connect collaboratively with faculty, as well as faculty who desire to make contact with companies. From arranging face-to-face meetings, to producing “science days” with confidential pipeline presentations followed by focused break-out sessions, we are here to help “connect the dots” where needed.
We also initiate, negotiate and operationally manage strategic alliances and partnerships, which may take many forms depending on the need.
SIV also manages the Office of Technology Commercialization (OTC). The primary goal is to establish license agreements with industry partners to transfer ideas and inventions developed by MD Anderson scientists to the commercial world.
The primary tools used to commercialize inventions are patents and license agreements.
10th: BioMed Valley Discoveries
4th: GlaxoSmith Kline
23rd and 24th: Texas FreshAIR
6th: Bayer Healthcare
2nd: Oxford BioTherapeutics
21st: Lilly Science Day